Sign In
Buy REGN
$618.95
+16.03 (+2.66%)
At Close: Jun 03, 2026
Regeneron Pharmaceuticals, Inc. $REGN Shares Acquired by Cerity Partners LLC
03:24am, Sunday, 11'th Jan 2026
Cerity Partners LLC grew its stake in Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) by 48.2% during the third quarter, according to its most recent 13F filing with the SEC. The firm owned 20,534 shar
Regeneron (REGN) Upgraded to Strong Buy: What Does It Mean for the Stock?
01:00pm, Friday, 09'th Jan 2026
Regeneron (REGN) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
Regeneron Pharmaceuticals, Inc. $REGN Stake Lifted by Clear Harbor Asset Management LLC
04:32am, Friday, 09'th Jan 2026
Clear Harbor Asset Management LLC increased its position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) by 26.3% during the undefined quarter, according to the company in its most recent
Regeneron Just Moved From Underperform To Buy - Here's Why
04:18pm, Wednesday, 07'th Jan 2026
Could the tide be turning for Regeneron Pharmaceuticals Inc. (NASDAQ: REGN) after a surprising shift in analyst sentiment?
Regeneron Pharmaceuticals upgraded by Bank of America on improving fundamentals, 2026 catalysts
02:17pm, Wednesday, 07'th Jan 2026
Regeneron Pharmaceuticals Inc (NASDAQ:REGN) has been upgraded by Bank of America, which raised its rating on the biotechnology company to ‘Buy' from ‘Underperform' and increased its price objectiv
Will Regeneron (REGN) Beat Estimates Again in Its Next Earnings Report?
01:10pm, Wednesday, 07'th Jan 2026
Regeneron (REGN) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
REGN vs. ILMN: Which Stock Is the Better Value Option?
12:41pm, Wednesday, 07'th Jan 2026
Investors interested in stocks from the Medical - Biomedical and Genetics sector have probably already heard of Regeneron (REGN) and Illumina (ILMN). But which of these two stocks offers value investo
M2i Global, Volato Group partner with Titanium X on US critical minerals development
09:33am, Wednesday, 07'th Jan 2026
M2i Global Inc (OTC:MTWO), along with Volato Group which is in the process of merging with the company, announced a strategic collaboration with Titanium X...
Regeneron Pharmaceuticals upgraded by Bank of America on improving fundamentals, 2026 catalysts
09:12am, Wednesday, 07'th Jan 2026
Regeneron Pharmaceuticals Inc (NASDAQ:REGN) has been upgraded by Bank of America, which raised its rating on the biotechnology company to ‘Buy’ from...
ReconAfrica upsizes financing to fast-track Kavango, Angola and Gabon programs
08:32am, Wednesday, 07'th Jan 2026
Reconnaissance Energy Africa Ltd (TSX-V:RECO, OTCQX:RECAF) has upsized its earlier private placement annoucement of C$20M to C$32M to fund a broad 2026...
Merit Financial Group LLC Has $1.05 Million Stock Position in Regeneron Pharmaceuticals, Inc. $REGN
05:20am, Wednesday, 07'th Jan 2026
Merit Financial Group LLC increased its stake in Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) by 302.4% during the third quarter, according to its most recent Form 13F filing with the SEC. The firm
Seeing Machines CEO on accelerated royalty payment & profit path
04:25am, Wednesday, 07'th Jan 2026
Seeing Machines Ltd (AIM:SEE, OTC:SEEMF) CEO Paul McGlone talked with Proactive's Stephen Gunnion about the company’s latest announcement regarding an...
REGN vs. ILMN: Which Stock Should Value Investors Buy Now?
12:41pm, Tuesday, 06'th Jan 2026
Investors interested in stocks from the Medical - Biomedical and Genetics sector have probably already heard of Regeneron (REGN) and Illumina (ILMN). But which of these two companies is the best optio
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
09:56am, Tuesday, 06'th Jan 2026
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
The Zacks Analyst Blog Eli Lilly, Medtronic, Intuitive Surgical, Regeneron Pharmaceuticals and Johnson & Johnson
05:41am, Tuesday, 06'th Jan 2026
Eli Lilly highlights how AI is transforming healthcare, from drug discovery to diagnostics, turning defensive medical stocks into growth plays for 2026.
